Top Clinical Trials companies in Israel by Total Assets

This ranking features the top 4 Clinical Trials companies in Israel ranked by Total Assets, totalling a Total Assets of USD 336.95 M, for January 15, 2025.

Israel

Clinical Trials
Total Assets
#
Name
Total Assets
 Reported Date
Stock Price
Change
 Price (30 days) Country
1
CGEN.TA

Compugen Ltd.

1

CGEN.TA
USD 121.33 M
Dec. 31, 2023 USD 1.85 10.75%

Israel
2
DRTS

Alpha Tau Medical Ltd.

2

DRTS
USD 107.39 M
Dec. 31, 2023 USD 4.00 8.11%

Israel
3
BLRX.TA

BioLineRx Ltd.

3

BLRX.TA
USD 63.92 M
Dec. 31, 2023 USD 0.01 -11.50%

Israel
4
PPBT.TA

Purple Biotech Ltd.

4

PPBT.TA
USD 44.30 M
Dec. 31, 2023 USD 0.02 -1.36%

Israel
Frequently Asked Questions
  • Which Clinical Trials company in Israel has the highest Total Assets ?

    The Clinical Trials company in Israel with the highest Total Assets is Compugen Ltd. (Tel Aviv Stock Exchange: CGEN.TA) at USD 121.33 M.

  • Which Clinical Trials company in Israel has the lowest Total Assets ?

    The Clinical Trials company in Israel with the lowest Total Assets is Purple Biotech Ltd. (Tel Aviv Stock Exchange: PPBT.TA) at USD 44.30 M.